Pfizer receives European approval for Oncology Biosimilar, RUXIENCE (rituximab) Medical Dialogues Bureau5 April 2020 8:45 AM GMTNew York: Pfizer Inc. has announced that the European Commission (EC) has approved RUXIENCE™ (rituximab), a monoclonal antibody (mAb) and biosimilar...
Roche MS drug Ocrevus wins European panel backing Ruby Khatun Khatun13 Nov 2017 4:32 AM GMTZURICH: Swiss drugmaker Roche on Friday won a key European panel's recommendation for its multiple sclerosis drug Ocrevus, which is on track for...
Europe ready to embrace first copies of biotech cancer drugs supriya kashyap kashyap17 Feb 2017 6:55 AM GMTLondon : Treatment with two important cancer drugs is about to get much cheaper in Europe with a cut-price copy of Roche's blood cancer drug Rituxan...